Heron Therapeutics | HRTX - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
ALKERMES USD 407.63M 73.6M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amarin USD 126.83M 477K 2025-12
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Eisai JPY 227B 22.05B 2026-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 178.55M 37.7M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Omeros USD 8.08M 440K 2024-06
Pacira USD 125.64M 1.57M 2026-03
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Veracyte USD 50.11M 5.45M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03